Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Development of a Green, Dual-Use Nebulization Device for Treatment of Acute and Chronic Lung Conditions

Reference number
Coordinator MucoLife Therapeutics AB
Funding from Vinnova SEK 200 000
Project duration May 2026 - May 2027
Status Ongoing
Venture Medtech4Health: Competence Enhancement in SME
Call Medtech4Health: Competence Enhancement in Small Businesses, spring 2026

Purpose and goal

The project aims to develop a plan for a new, environmentally sustainable nebulizer that can rapidly deliver a drug to dissolve mucus plugs in the lungs. The solution will work both in healthcare and in emergency situations, improving treatment for serious lung diseases while strengthening societal preparedness.

Expected effects and result

The project will deliver a decision-ready development plan for a green, dual-use nebulization device, reducing technical and regulatory risks. In the long term, it will enable faster and more effective treatment of severe lung diseases while strengthening healthcare systems and societal preparedness in emergency situations.

Planned approach and implementation

The project will be carried out in two phases. First, technical solutions, drug–device compatibility, sustainability, and regulatory requirements will be analyzed. Next, a development plan will be created, including target profile, regulatory strategy, and commercialization pathway. The work will be conducted in close collaboration with external experts and guided by structured analyses and decision points.

External links

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 12 May 2026

Reference number 2026-00551